Aquestive Therapeutics, Inc. (AQST) Revenue History
Aquestive Therapeutics, Inc. (AQST) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | $67.43M |
| 2019-12-31 | $52.61M |
| 2020-12-31 | $45.85M |
| 2021-12-31 | $50.83M |
| 2022-12-31 | $47.68M |
| 2023-12-31 | $50.58M |
| 2024-12-31 | $57.56M |
| 2025-12-31 | $44.55M |
How AQST compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| AGIO | Agios Pharmaceuticals Inc. | $54.03M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
These are five companies in the same sector as AQST with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Aquestive Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AQST", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AQST | $4.66 | +3.67% | 2.02M |
| 3 | ||||
| 4 | ||||
| 5 |